Systematic review of the effectiveness of pharmacological treatments for adolescents and adults with autism spectrum disorder
- PMID:17656398
- DOI: 10.1177/1362361307078132
Systematic review of the effectiveness of pharmacological treatments for adolescents and adults with autism spectrum disorder
Abstract
The variable expression of autism over the lifespan is likely to lead to different symptoms and support requirements, and to distinct responses to pharmacotherapy treatment, in older patients compared to children. This systematic review considers the effectiveness of pharmacological treatment in managing autism spectrum disorder in adolescents and adults. Following a comprehensive search of literature published in English from 1980, methodological criteria were applied to identify studies designed to reliably assess treatment effectiveness. Only five double-blind, randomized controlled trials were eligible for appraisal. All had small sample sizes (mean = 30) and brief treatment duration of no more than 12 weeks. The paucity of trials and their methodological limitations means that there is only preliminary evidence about the short-term effectiveness of a few drug treatments for this age group. There was also a lack of reliable data reported on drug safety profiles. Methodological challenges and directions for future research are discussed.
Similar articles
- [Review of psychopharmacological treatments in adolescents and adults with autistic disorders].Baghdadli A, Gonnier V, Aussilloux C.Baghdadli A, et al.Encephale. 2002 May-Jun;28(3 Pt 1):248-54.Encephale. 2002.PMID:12091786Review.French.
- Psychological therapies for the treatment of post-traumatic stress disorder in children and adolescents (Review).Gillies D, Taylor F, Gray C, O'Brien L, D'Abrew N.Gillies D, et al.Evid Based Child Health. 2013 May;8(3):1004-116. doi: 10.1002/ebch.1916.Evid Based Child Health. 2013.PMID:23877914Review.
- Aripiprazole for treating irritability in children & adolescents with autism: A systematic review.Ghanizadeh A, Tordjman S, Jaafari N.Ghanizadeh A, et al.Indian J Med Res. 2015 Sep;142(3):269-75. doi: 10.4103/0971-5916.166584.Indian J Med Res. 2015.PMID:26458342Free PMC article.Review.
- Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholesterolemia: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].Lozano P, Henrikson NB, Dunn J, Morrison CC, Nguyen M, Blasi PR, Anderson ML, Whitlock E.Lozano P, et al.Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Aug. Report No.: 14-05204-EF-2.Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Aug. Report No.: 14-05204-EF-2.PMID:27559556Free Books & Documents.Review.
- Methodological issues in designing a multisite trial of risperidone in children and adolescents with autism.Scahill L, McCracken J, McDougle CJ, Aman M, Arnold LE, Tierney E, Cronin P, Davies M, Ghuman J, Gonzalez N, Koenig K, Lindsay R, Martin A, McGough J, Posey DJ, Swiezy N, Volkmar F, Ritz L, Vitiello B.Scahill L, et al.J Child Adolesc Psychopharmacol. 2001 Winter;11(4):377-88. doi: 10.1089/104454601317261555.J Child Adolesc Psychopharmacol. 2001.PMID:11838820Clinical Trial.
Cited by
- Autism spectrum disorder in adults: diagnosis, management, and health services development.Murphy CM, Wilson CE, Robertson DM, Ecker C, Daly EM, Hammond N, Galanopoulos A, Dud I, Murphy DG, McAlonan GM.Murphy CM, et al.Neuropsychiatr Dis Treat. 2016 Jul 7;12:1669-86. doi: 10.2147/NDT.S65455. eCollection 2016.Neuropsychiatr Dis Treat. 2016.PMID:27462160Free PMC article.Review.
- A longitudinal investigation of psychotropic and non-psychotropic medication use among adolescents and adults with autism spectrum disorders.Esbensen AJ, Greenberg JS, Seltzer MM, Aman MG.Esbensen AJ, et al.J Autism Dev Disord. 2009 Sep;39(9):1339-49. doi: 10.1007/s10803-009-0750-3. Epub 2009 May 12.J Autism Dev Disord. 2009.PMID:19434487Free PMC article.
- Associations between atypical intracortical myelin content and neuropsychological functions in middle to older aged adults with ASD.Kohli JS, Linke AC, Martindale IA, Wilkinson M, Kinnear MK, Lincoln AJ, Hau J, Shryock I, Omaleki V, Alemu K, Pedrahita S, Fishman I, Müller RA, Carper RA.Kohli JS, et al.Brain Behav. 2024 Jun;14(6):e3594. doi: 10.1002/brb3.3594.Brain Behav. 2024.PMID:38849980Free PMC article.
- An endocannabinoid-regulated basolateral amygdala-nucleus accumbens circuit modulates sociability.Folkes OM, Báldi R, Kondev V, Marcus DJ, Hartley ND, Turner BD, Ayers JK, Baechle JJ, Misra MP, Altemus M, Grueter CA, Grueter BA, Patel S.Folkes OM, et al.J Clin Invest. 2020 Apr 1;130(4):1728-1742. doi: 10.1172/JCI131752.J Clin Invest. 2020.PMID:31874107Free PMC article.
- Facing your fears in adolescence: cognitive-behavioral therapy for high-functioning autism spectrum disorders and anxiety.Reaven J, Blakeley-Smith A, Leuthe E, Moody E, Hepburn S.Reaven J, et al.Autism Res Treat. 2012;2012:423905. doi: 10.1155/2012/423905. Epub 2012 Oct 3.Autism Res Treat. 2012.PMID:23091719Free PMC article.
Publication types
MeSH terms
Related information
LinkOut - more resources
Full Text Sources